{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:32:21Z","timestamp":1791999141466,"version":"4.4.0"},"reference-count":233,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Diffuse large B-cell lymphoma and follicular lymphoma exhibit complex metabolic and immune microenvironments that influence disease progression and treatment response. Metabolic reprogramming, including glycolysis, amino acid, and lipid metabolism, supports tumor growth while suppressing anti-tumor immunity. Immune components such as tumor-infiltrating lymphocytes and checkpoint molecules (PD-L1, LAG-3, TIM-3) further modulate prognosis. Elevated tumor metabolic volume and glycolytic activity correlate with aggressive disease and poor outcomes. Conversely, high TIL density often predicts better responses. Integrating metabolic and immune biomarkers enhances risk stratification and therapeutic strategies, highlighting the potential for combined metabolic inhibitors and immunotherapies to improve precision medicine in lymphoma.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1659011","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T05:51:09Z","timestamp":1759297869000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Metabolic-immune axis in the tumor microenvironment: a new strategy for prognostic assessment and precision therapy in DLBCL and FL"],"prefix":"10.3389","volume":"16","author":[{"given":"Chengqian","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haotian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luming","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ou","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-024-03879-w","article-title":"Current treatment approach and future perspectives in B cell lymphoma","volume":"121","author":"Yamauchi","year":"2025","journal-title":"Int J Hematol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1288110","article-title":"Modeling the crosstalk between Malignant B cells and their microenvironment in B-cell lymphomas: challenges and opportunities","volume":"14","author":"Brauge","year":"2023","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-024-03774-z","article-title":"Mutational, immune microenvironment, and clinicopathological profiles of diffuse large B-cell lymphoma and follicular lymphoma with bcl6 rearrangement","volume":"484","author":"Carreras","year":"2024","journal-title":"Virchows Arch"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1200\/jco.22.01848","article-title":"Navigating the evolving treatment landscape of diffuse large B-cell lymphoma","volume":"41","author":"Nastoupil","year":"2023","journal-title":"J Clin Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2012.12.009","article-title":"Diffuse large B-cell lymphoma","volume":"87","author":"Martelli","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41572-019-0132-x","article-title":"Follicular lymphoma","volume":"5","author":"Carbone","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"B7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2147\/blctt.S282247","article-title":"A promising future for precision epigenetic therapy for follicular and diffuse large B-cell lymphoma","volume":"12","author":"Chung","year":"2022","journal-title":"Blood Lymphat Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(11)70235-2","article-title":"Chop-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the mabthera international trial (Mint) group","volume":"12","author":"Pfreundschuh","year":"2011","journal-title":"Lancet Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy113","article-title":"Methodology of clinical trials evaluating the incorporation of new drugs in the first-line treatment of patients with diffuse large B-cell lymphoma (Dlbcl): A critical review","volume":"29","author":"Iacoboni","year":"2018","journal-title":"Ann Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-025-01297-6","article-title":"Advances in personalized treatment and prognostic factors of follicular lymphoma","volume":"26","author":"Cheng","year":"2025","journal-title":"Curr Treat Options Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13045-021-01113-2","article-title":"Evolving therapeutic landscape in follicular lymphoma: A look at emerging and investigational therapies","volume":"14","author":"Hanel","year":"2021","journal-title":"J Hematol Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1200\/jco.23.00570","article-title":"Relapse timing is associated with distinct evolutionary dynamics in diffuse large B-cell lymphoma","volume":"41","author":"Hilton","year":"2023","journal-title":"J Clin Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13045-025-01702-5","article-title":"Therapeutic landscape of primary refractory and relapsed diffuse large B-cell lymphoma: recent advances and emerging therapies","volume":"18","author":"Bock","year":"2025","journal-title":"J Hematol Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s40364-023-00525-1","article-title":"Survival of patients with transformed follicular lymphoma in the United States: A multiple cohort study","volume":"11","author":"Vaughn","year":"2023","journal-title":"biomark Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35378","article-title":"Early histological transformation of follicular lymphoma to diffuse large B-cell lymphoma indicating adverse survival: A population-based analysis and validation","volume":"130","author":"Li","year":"2024","journal-title":"Cancer"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.805195","article-title":"Epigenetic, metabolic, and immune crosstalk in germinal-center-derived B-cell lymphomas: unveiling new vulnerabilities for rational combination therapies","volume":"9","author":"Serganova","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/metabo11010028","article-title":"Metabolic reprogramming of cancer cells during tumor progression and metastasis","volume":"11","author":"Ohshima","year":"2021","journal-title":"Metabolites"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12416","article-title":"Tumor microenvironment signaling and therapeutics in cancer progression","volume":"43","author":"Goenka","year":"2023","journal-title":"Cancer Commun (Lond)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.994520","article-title":"Repeatability of metabolic tumor burden and lesion glycolysis between clinical readers","volume":"14","author":"Choi","year":"2023","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1283582","article-title":"Metabolic bulk volume from fdg pet as an independent predictor of progression-free survival in follicular lymphoma","volume":"13","author":"So","year":"2023","journal-title":"Front Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2025.08.003","article-title":"Prognostic value of 18f-fdg pet\/ct parameters at baseline and end of treatment in follicular lymphoma: A systematic review and meta-analysis","author":"Wang","year":"2025","journal-title":"Acad Radiol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-21-3140","article-title":"Clinical impact of immune cells and their spatial interactions in diffuse large B-cell lymphoma microenvironment","volume":"28","author":"Autio","year":"2022","journal-title":"Clin Cancer Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1335689","article-title":"Flow cytometry quantification of tumor-infiltrating lymphocytes to predict the survival of patients with diffuse large B-cell lymphoma","volume":"15","author":"Yu","year":"2024","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.4132\/jptm.2023.11.02","article-title":"Tumor-infiltrating T lymphocytes evaluated using digital image analysis predict the prognosis of patients with diffuse large B-cell lymphoma","volume":"58","author":"Cho","year":"2024","journal-title":"J Pathol Transl Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.943354","article-title":"Regulatory T cells (Tregs) in lymphoid Malignancies and the impact of novel therapies","volume":"13","author":"Maharaj","year":"2022","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109235","article-title":"Tumor-associated macrophages in lymphoma: from mechanisms to therapy","volume":"112","author":"Xiong","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3038","article-title":"Otto warburg\u2019s contributions to current concepts of cancer metabolism","volume":"11","author":"Koppenol","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"B28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.molmet.2019.07.006","article-title":"Monocarboxylate transporters in cancer","volume":"33","author":"Payen","year":"2020","journal-title":"Mol Metab"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2023.01.007","article-title":"Targeting monocarboxylate transporters (Mcts) in cancer: how close are we to the clinics","volume":"90","author":"Singh","year":"2023","journal-title":"Semin Cancer Biol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02082-x","article-title":"Lactate and lactylation in cancer","volume":"10","author":"Chen","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.08.011","article-title":"Ldha-associated lactic acid production blunts tumor immunosurveillance by T and nk cells","volume":"24","author":"Brand","year":"2016","journal-title":"Cell Metab"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.10.015","article-title":"Lactate wreaks havoc on tumor-infiltrating T and nk cells","volume":"24","author":"Scott","year":"2016","journal-title":"Cell Metab"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-035972","article-title":"Inhibitory effect of tumor cell-derived lactic acid on human T cells","volume":"109","author":"Fischer","year":"2007","journal-title":"Blood"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1172\/jci175897","article-title":"Lactate supports treg function and immune balance via mgat1 effects on N-glycosylation in the mitochondria","volume":"134","author":"Zhou","year":"2024","journal-title":"J Clin Invest"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.932055","article-title":"Lactate from the tumor microenvironment - a key obstacle in nk cell-based immunotherapies","volume":"13","author":"Jedli\u010dka","year":"2022","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216896","article-title":"Lactate and lactylation: behind the development of tumors","volume":"591","author":"Dai","year":"2024","journal-title":"Cancer Lett"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-05-1795","article-title":"Tumor-derived lactic acid modulates dendritic cell activation and antigen expression","volume":"107","author":"Gottfried","year":"2006","journal-title":"Blood"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2024-264218","article-title":"Type a versus type B lactic acidosis in the context of undiagnosed B-cell lymphoma","volume":"18","author":"Kundu","year":"2025","journal-title":"BMJ Case Rep"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1177\/03000605211067749","article-title":"Type B lactic acidosis associated with diffuse large B-cell lymphoma and the warburg effect","volume":"50","author":"Wang","year":"2022","journal-title":"J Int Med Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.26557","article-title":"An oncological emergency: severe type B lactic acidosis from warburg effect in diffuse large B-cell lymphoma","volume":"14","author":"Sanivarapu","year":"2022","journal-title":"Cureus"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70824","article-title":"Tumor-associated lactic acidosis and early death in patients with lymphoma","volume":"14","author":"Atamna","year":"2025","journal-title":"Cancer Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2017.05.016","article-title":"Consideration of alternative causes of lactic acidosis: thiamine deficiency in Malignancy","volume":"35","author":"Dean","year":"2017","journal-title":"Am J Emerg Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/08998280.2017.11929534","article-title":"B-cell lymphoma, thiamine deficiency, and lactic acidosis","volume":"30","author":"Masood","year":"2017","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3390\/nu12092810","article-title":"The relevance of thiamine evaluation in a practical setting","volume":"12","author":"Pacei","year":"2020","journal-title":"Nutrients"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2804","article-title":"Clinical significance of tryptophan catabolism in follicular lymphoma","volume":"38","author":"Masaki","year":"2020","journal-title":"Hematol Oncol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-006728","article-title":"Tryptophan depletion sensitizes the ahr pathway by increasing ahr expression and gcn2\/lat1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes","volume":"11","author":"Solvay","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B48","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1038\/s41467-020-17750-z","article-title":"Blockade of the ahr restricts a treg-macrophage suppressive axis induced by L-kynurenine","volume":"11","author":"Campesato","year":"2020","journal-title":"Nat Commun"},{"key":"B49","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.ccell.2018.02.005","article-title":"Tumor-repopulating cells induce pd-1 expression in cd8(+) T cells by transferring kynurenine and ahr activation","volume":"33","author":"Liu","year":"2018","journal-title":"Cancer Cell"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-14-2275","article-title":"Prognostic significance of tryptophan catabolism in adult T-cell leukemia\/lymphoma","volume":"21","author":"Masaki","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.5903","article-title":"Expression of tryptophan metabolism enzymes in patients with diffuse large B-cell lymphoma and nk\/T-cell lymphoma","volume":"12","author":"Guo","year":"2023","journal-title":"Cancer Med"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-015-1835-8","article-title":"Effects of indoleamine 2,3-dioxygenase inhibitor in non-hodgkin lymphoma model mice","volume":"102","author":"Nakamura","year":"2015","journal-title":"Int J Hematol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2015.2825","article-title":"The tryptophan derivative, tranilast, and conditioned medium with indoleamine 2,3-dioxygenase-expressing cells inhibit the proliferation of lymphoid Malignancies","volume":"46","author":"Suwa","year":"2015","journal-title":"Int J Oncol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13045-017-0397-z","article-title":"Mesenchymal stromal cells as vehicles of tetravalent bispecific tandab (Cd3\/cd19) for the treatment of B cell lymphoma combined with ido pathway inhibitor D-1-methyl-tryptophan","volume":"10","author":"Zhang","year":"2017","journal-title":"J Hematol Oncol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.81","article-title":"Serine and one-carbon metabolism in cancer","volume":"16","author":"Yang","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-024-01268-1","article-title":"Phgdh: A novel therapeutic target in cancer","volume":"56","author":"Lee","year":"2024","journal-title":"Exp Mol Med"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1172\/jci153436","article-title":"Phgdh is required for germinal center formation and is a therapeutic target in myc-driven lymphoma","volume":"132","author":"D\u2019Avola","year":"2022","journal-title":"J Clin Invest"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-024-01134-0","article-title":"Targeting phgdh reverses the immunosuppressive phenotype of tumor-associated macrophages through A-ketoglutarate and mtorc1 signaling","volume":"21","author":"Cai","year":"2024","journal-title":"Cell Mol Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.celrep.2020.01.011","article-title":"Inverse data-driven modeling and multiomics analysis reveals phgdh as a metabolic checkpoint of macrophage polarization and proliferation","volume":"30","author":"Wilson","year":"2020","journal-title":"Cell Rep"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-020-00504-8","article-title":"Glutamine reliance in cell metabolism","volume":"52","author":"Yoo","year":"2020","journal-title":"Exp Mol Med"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2019.03.003","article-title":"Glutamine as an essential amino acid for kras-driven cancer cells","volume":"30","author":"Bernfeld","year":"2019","journal-title":"Trends Endocrinol Metab"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903586","article-title":"Glutamine uptake and metabolism are coordinately regulated by erk\/mapk during T lymphocyte activation","volume":"185","author":"Carr","year":"2010","journal-title":"J Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1172\/jci131859","article-title":"Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells","volume":"130","author":"Oh","year":"2020","journal-title":"J Clin Invest"},{"key":"B64","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.molcel.2020.10.015","article-title":"Inhibition of glutamine utilization synergizes with immune checkpoint inhibitor to promote antitumor immunity","volume":"80","author":"Byun","year":"2020","journal-title":"Mol Cell"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24132367","article-title":"The metabolomic profile of lymphoma subtypes: A pilot study","volume":"24","author":"Barberini","year":"2019","journal-title":"Molecules"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023010964","article-title":"Inhibition of glutaminase-1 in dlbcl potentiates venetoclax-induced antitumor activity by promoting oxidative stress","volume":"7","author":"Gomez Solsona","year":"2023","journal-title":"Blood Adv"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abq0117","article-title":"Mitochondrial pyruvate supports lymphoma proliferation by fueling a glutamate pyruvate transaminase 2-dependent glutaminolysis pathway","volume":"8","author":"Wei","year":"2022","journal-title":"Sci Adv"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2012.08.014","article-title":"Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma","volume":"22","author":"Caro","year":"2012","journal-title":"Cancer Cell"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2016.116","article-title":"Differential contribution of the mitochondrial translation pathway to the survival of diffuse large B-cell lymphoma subsets","volume":"24","author":"Norberg","year":"2017","journal-title":"Cell Death Differ"},{"key":"B70","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1158\/2643-3230.Bcd-20-0183","article-title":"Translational activation of atf4 through mitochondrial anaplerotic metabolic pathways is required for dlbcl growth and survival","volume":"3","author":"Li","year":"2022","journal-title":"Blood Cancer Discov"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2024.101288","article-title":"Leveraging altered lipid metabolism in treating B cell Malignancies","volume":"95","author":"Lee","year":"2024","journal-title":"Prog Lipid Res"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15349","article-title":"Blocking cholesterol efflux mechanism is a potential target for antilymphoma therapy","volume":"113","author":"Yano","year":"2022","journal-title":"Cancer Sci"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.608238","article-title":"Alteration of cholesterol metabolism by metformin is associated with improved outcome in type ii diabetic patients with diffuse large B-cell lymphoma","volume":"11","author":"Jiang","year":"2021","journal-title":"Front Oncol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-024-02017-z","article-title":"A novel lipid metabolism-based risk model associated with immunosuppressive mechanisms in diffuse large B-cell lymphoma","volume":"23","author":"Zhang","year":"2024","journal-title":"Lipids Health Dis"},{"key":"B75","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s10020-024-00988-4","article-title":"Lipid metabolism-related gene signature predicts prognosis and unveils novel anti-tumor drugs in specific type of diffuse large B cell lymphoma","volume":"30","author":"Wang","year":"2024","journal-title":"Mol Med"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2009.23.4245","article-title":"Statin use and prognosis in patients with diffuse large B-cell lymphoma and follicular lymphoma in the rituximab era","volume":"28","author":"Nowakowski","year":"2010","journal-title":"J Clin Oncol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.Cir-18-0095","article-title":"Ppar-induced fatty acid oxidation in T cells increases the number of tumor-reactive cd8(+) T cells and facilitates anti-pd-1 therapy","volume":"6","author":"Chowdhury","year":"2018","journal-title":"Cancer Immunol Res"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-23-0287","article-title":"Fatty acids support the fitness and functionality of tumor-resident cd8+ T cells by maintaining scml4 expression","volume":"83","author":"Feng","year":"2023","journal-title":"Cancer Res"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.cmet.2021.02.015","article-title":"Cd36-mediated ferroptosis dampens intratumoral cd8(+) T cell effector function and impairs their antitumor ability","volume":"33","author":"Ma","year":"2021","journal-title":"Cell Metab"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.immuni.2021.05.003","article-title":"Uptake of oxidized lipids by the scavenger receptor cd36 promotes lipid peroxidation and dysfunction in cd8(+) T cells in tumors","volume":"54","author":"Xu","year":"2021","journal-title":"Immunity"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-020-0382-2","article-title":"The adenosine pathway in immuno-oncology","volume":"17","author":"Allard","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.86","article-title":"Targeting immunosuppressive adenosine in cancer","volume":"17","author":"Vijayan","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000186","article-title":"On the mechanism of anti-cd39 immune checkpoint therapy","volume":"8","author":"Allard","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1042\/bj20020439","article-title":"The evidence for two opposite, atp-generating and atp-consuming, extracellular pathways on endothelial and lymphoid cells","volume":"367","author":"Yegutkin","year":"2002","journal-title":"Biochem J"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01794-9","article-title":"Inhibition of cd39 unleashes macrophage antibody-dependent cellular phagocytosis against B-cell lymphoma","volume":"37","author":"Casey","year":"2023","journal-title":"Leukemia"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0811-3","article-title":"Targeting an adenosine-mediated \u201cDon\u2019t eat me signal\u201d Augments anti-lymphoma immunity by anti-cd20 monoclonal antibody","volume":"34","author":"Nakamura","year":"2020","journal-title":"Leukemia"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0900475","article-title":"Human follicular lymphoma cd39+-infiltrating T cells contribute to adenosine-mediated T cell hyporesponsiveness","volume":"183","author":"Hilchey","year":"2009","journal-title":"J Immunol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-91287-5_27","article-title":"Hypoxia-\/hif-1\u03b1-driven factors of the tumor microenvironment impeding antitumor immune responses and promoting Malignant progression","volume":"1072","author":"Vaupel","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-34461-0_21","article-title":"Fatal alliance of hypoxia-\/hif-1\u03b1-driven microenvironmental traits promoting cancer progression","volume":"1232","author":"Vaupel","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2016.06.009","article-title":"A2a adenosine receptor antagonists to weaken the hypoxia-hif-1\u03b1 Driven immunosuppression and improve immunotherapies of cancer","volume":"29","author":"Hatfield","year":"2016","journal-title":"Curr Opin Pharmacol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-014-1189-3","article-title":"Systemic oxygenation weakens the hypoxia and hypoxia inducible factor 1\u03b1-dependent and extracellular adenosine-mediated tumor protection","volume":"92","author":"Hatfield","year":"2014","journal-title":"J Mol Med (Berl)"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009245","article-title":"Blocking the cd39\/cd73 pathway synergizes with anti-cd20 bispecific antibody in nodal B-cell lymphoma","volume":"13","author":"Kolbe","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004114","article-title":"Genetic characteristics involving the pd-1\/pd-L1\/L2 and cd73\/A2ar axes and the immunosuppressive microenvironment in dlbcl","volume":"10","author":"Zhang","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2023.07.015","article-title":"Modulating treg stability to improve cancer immunotherapy","volume":"9","author":"Kang","year":"2023","journal-title":"Trends Cancer"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2022.06.008","article-title":"Therapeutic targeting of regulatory T cells in cancer","volume":"8","author":"Shan","year":"2022","journal-title":"Trends Cancer"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002591","article-title":"Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies","volume":"9","author":"Nishikawa","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cmet.2016.12.018","article-title":"Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments","volume":"25","author":"Angelin","year":"2017","journal-title":"Cell Metab"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2017.05.012","article-title":"Treg cells survive and thrive in inhospitable environments","volume":"25","author":"Grzes","year":"2017","journal-title":"Cell Metab"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1038\/nature23665","article-title":"Homeostatic control of metabolic and functional fitness of T(Reg) cells by lkb1 signalling","volume":"548","author":"Yang","year":"2017","journal-title":"Nature"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1715363114","article-title":"Metabolic control of regulatory T cell (Treg) survival and function by lkb1","volume":"114","author":"He","year":"2017","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1038\/nri2808","article-title":"The polarization of immune cells in the tumour environment by tgfbeta","volume":"10","author":"Flavell","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3800","article-title":"Tumor immunoevasion by the conversion of effector nk cells into type 1 innate lymphoid cells","volume":"18","author":"Gao","year":"2017","journal-title":"Nat Immunol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0346-9","article-title":"Adaptive plasticity of il-10(+) and il-35(+) T(Reg) cells cooperatively promotes tumor T cell exhaustion","volume":"20","author":"Sawant","year":"2019","journal-title":"Nat Immunol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.01.013","article-title":"Interleukin-35 limits anti-tumor immunity","volume":"44","author":"Turnis","year":"2016","journal-title":"Immunity"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-03045-2","article-title":"Metabolic support of tumour-infiltrating regulatory T cells by lactic acid","volume":"591","author":"Watson","year":"2021","journal-title":"Nature"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03235-6","article-title":"Lipid signalling enforces functional specialization of T(Reg) cells in tumours","volume":"591","author":"Lim","year":"2021","journal-title":"Nature"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903670","article-title":"An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells","volume":"185","author":"Mezrich","year":"2010","journal-title":"J Immunol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2020.12.005","article-title":"Targeting adenosine and regulatory T cells in cancer immunotherapy","volume":"82","author":"Churov","year":"2021","journal-title":"Hum Immunol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023010158","article-title":"Diversity of intratumoral regulatory T cells in B-cell non-hodgkin lymphoma","volume":"7","author":"Spasevska","year":"2023","journal-title":"Blood Adv"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1309\/ajcpujgmvv6zf4gg","article-title":"High levels of regulatory T cells in blood are a poor prognostic factor in patients with diffuse large B-cell lymphoma","volume":"144","author":"Chang","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2993","article-title":"Elevated serum il-13 level is associated with increased treg cells in tumor microenvironment and disease progression of diffuse large B-cell lymphoma","volume":"41","author":"Li","year":"2023","journal-title":"Hematol Oncol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1186\/s12967-022-03588-0","article-title":"Lkb1 aggravates diffuse large B-cell lymphoma by promoting the function of treg cells and immune escape","volume":"20","author":"Su","year":"2022","journal-title":"J Transl Med"},{"key":"B113","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.molmed.2017.11.005","article-title":"Metabolic control of cd8(+) T cell fate decisions and antitumor immunity","volume":"24","author":"Zhang","year":"2018","journal-title":"Trends Mol Med"},{"key":"B114","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.tcb.2020.06.003","article-title":"The roles of cd8(+) T cell subsets in antitumor immunity","volume":"30","author":"St Paul","year":"2020","journal-title":"Trends Cell Biol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002954","article-title":"Mitochondrial reactive oxygen species trigger metformin-dependent antitumor immunity via activation of nrf2\/mtorc1\/P62 axis in tumor-infiltrating cd8t lymphocytes","volume":"9","author":"Nishida","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf6284","article-title":"Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism","volume":"354","author":"Peng","year":"2016","journal-title":"Science"},{"key":"B117","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40364-020-00228-x","article-title":"Roles of ifn-\u0393 in tumor progression and regression: A review","volume":"8","author":"Jorgovanovic","year":"2020","journal-title":"biomark Res"},{"key":"B118","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ctrv.2017.01.009","article-title":"Targeting the programmed death-1 pathway in lymphoid neoplasms","volume":"54","author":"Ok","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2015.1008824","article-title":"Interferon-\u0393-induced activation of jak1 and jak2 suppresses tumor cell susceptibility to nk cells through upregulation of pd-L1 expression","volume":"4","author":"Bellucci","year":"2015","journal-title":"Oncoimmunology"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.2147\/ott.S187280","article-title":"Anti-pd1 up-regulates pd-L1 expression and inhibits T-cell lymphoma progression: possible involvement of an ifn-\u0393-associated jak-stat pathway","volume":"12","author":"Xue","year":"2019","journal-title":"Onco Targets Ther"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202403019R","article-title":"Metabolic reprogramming of glycolysis, lipids, and amino acids in tumors: impact on cd8+ T cell function and targeted therapeutic strategies","volume":"39","author":"Liang","year":"2025","journal-title":"FASEB J"},{"key":"B122","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12935-021-01978-w","article-title":"Dynamic changes in peripheral blood lymphocyte subset counts and functions in patients with diffuse large B cell lymphoma during chemotherapy","volume":"21","author":"Hou","year":"2021","journal-title":"Cancer Cell Int"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.282265","article-title":"Low T-cell proportion in the tumor microenvironment is associated with immune escape and poor survival in diffuse large B-cell lymphoma","volume":"108","author":"Song","year":"2023","journal-title":"Haematologica"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112447","article-title":"The significance of cd8(+) tumor-infiltrating lymphocytes exhaustion heterogeneity and its underlying mechanism in diffuse large B-cell lymphoma","volume":"137","author":"Zhu","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-11-0264","article-title":"T cells in tumors and blood predict outcome in follicular lymphoma treated with rituximab","volume":"17","author":"Wahlin","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1002\/hon.3003","article-title":"High inter-follicular spatial co-localization of cd8+Foxp3+ with cd4+Cd8+ Cells predicts favorable outcome in follicular lymphoma","volume":"40","author":"Hagos","year":"2022","journal-title":"Hematol Oncol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.immuni.2022.12.008","article-title":"Microenvironment-driven metabolic adaptations guiding cd8(+) T cell anti-tumor immunity","volume":"56","author":"Park","year":"2023","journal-title":"Immunity"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1172\/jci154152","article-title":"Lfa-1 activation enriches tumor-specific T cells in a cold tumor model and synergizes with ctla-4 blockade","volume":"132","author":"Hickman","year":"2022","journal-title":"J Clin Invest"},{"key":"B129","doi-asserted-by":"publisher","first-page":"5183","DOI":"10.1038\/s41467-024-49495-4","article-title":"Cholesterol efflux from C1qb-expressing macrophages is associated with resistance to chimeric antigen receptor T cell therapy in primary refractory diffuse large B cell lymphoma","volume":"15","author":"Yan","year":"2024","journal-title":"Nat Commun"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002662","article-title":"Expression of klrg1 and cd127 defines distinct cd8(+) subsets that differentially impact patient outcome in follicular lymphoma","volume":"9","author":"Wu","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1172\/jci166070","article-title":"Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma","volume":"133","author":"Apollonio","year":"2023","journal-title":"J Clin Invest"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2021.06.006","article-title":"Lymph node fibroblastic reticular cells steer immune responses","volume":"42","author":"Li","year":"2021","journal-title":"Trends Immunol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2025.02.002","article-title":"Lymph node fibroblast-produced extracellular matrix shapes immune function","volume":"46","author":"Panocha","year":"2025","journal-title":"Trends Immunol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217475","article-title":"Fap upregulates pd-L1 expression in cancer-associated fibroblasts to exacerbate T cells dysfunction and suppress anti-tumor immunity","volume":"612","author":"Wei","year":"2025","journal-title":"Cancer Lett"},{"key":"B135","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13045-023-01478-6","article-title":"Metabolism, metabolites, and macrophages in cancer","volume":"16","author":"Li","year":"2023","journal-title":"J Hematol Oncol"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-025-00909-2","article-title":"Linking macrophage metabolism to function in the tumor microenvironment","volume":"6","author":"Jin","year":"2025","journal-title":"Nat Cancer"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1295257","article-title":"Tumor-associated macrophages: an effective player of the tumor microenvironment","volume":"14","author":"Basak","year":"2023","journal-title":"Front Immunol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.canlet.2019.03.015","article-title":"Metabolic reprogramming of macrophages during infections and cancer","volume":"452","author":"Wang","year":"2019","journal-title":"Cancer Lett"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1042\/cs20220531","article-title":"M1\/M2 macrophages and their overlaps - myth or reality","volume":"137","author":"Strizova","year":"2023","journal-title":"Clin Sci (Lond)"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.101041","article-title":"The promising role of tumor-associated macrophages in the treatment of cancer","volume":"73","author":"Wang","year":"2024","journal-title":"Drug Resist Update"},{"key":"B141","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cytogfr.2022.11.001","article-title":"Crosstalk between glucose metabolism, lactate production and immune response modulation","volume":"68","author":"Ye","year":"2022","journal-title":"Cytokine Growth Factor Rev"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-020-00251-y","article-title":"Metabolic reprogramming in macrophage responses","volume":"9","author":"Liu","year":"2021","journal-title":"biomark Res"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.3390\/cells10113194","article-title":"Macrophage reprogramming and cancer therapeutics: role of inos-derived no","volume":"10","author":"Kashfi","year":"2021","journal-title":"Cells"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/9029327","article-title":"Hif1\u03b1-induced glycolysis metabolism is essential to the activation of inflammatory macrophages","volume":"2017","author":"Wang","year":"2017","journal-title":"Mediators Inflammation"},{"key":"B145","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.ccell.2024.05.011","article-title":"Integrated single cell analysis reveals co-evolution of Malignant B cells and tumor micro-environment in transformed follicular lymphoma","volume":"42","author":"Sarkozy","year":"2024","journal-title":"Cancer Cell"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005722","article-title":"Follicular lymphoma and macrophages: impact of approved and novel therapies","volume":"5","author":"Gouni","year":"2021","journal-title":"Blood Adv"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2022.101614","article-title":"Expression of glucose transporter-1 in follicular lymphoma affected tumor-infiltrating immunocytes and was related to progression of disease within 24 months","volume":"28","author":"Deng","year":"2023","journal-title":"Transl Oncol"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.3960\/jslrt.53.127","article-title":"Role of stat3 activation in cell-cell interaction between B-cell lymphoma and macrophages: the in vitro study","volume":"53","author":"Bai","year":"2013","journal-title":"J Clin Exp Hematop"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.583084","article-title":"Tumor-associated macrophages in tumor immunity","volume":"11","author":"Pan","year":"2020","journal-title":"Front Immunol"},{"key":"B150","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","article-title":"Macrophages as tools and targets in cancer therapy","volume":"21","author":"Mantovani","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0127-6","article-title":"Macrophages as regulators of tumour immunity and immunotherapy","volume":"19","author":"DeNardo","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B152","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nrd.2018.169","article-title":"Targeting macrophages: therapeutic approaches in cancer","volume":"17","author":"Cassetta","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00049","article-title":"Targeting macrophages in cancer: from bench to bedside","volume":"8","author":"Poh","year":"2018","journal-title":"Front Oncol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107788","article-title":"A novel ezh1\/2 dual inhibitor inhibits gcb dlbcl through cell cycle regulation and M2 tumor-associated macrophage polarization","volume":"300","author":"An","year":"2024","journal-title":"J Biol Chem"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01201-9","article-title":"The receptor of the colony-stimulating factor-1 (Csf-1r) is a novel prognostic factor and therapeutic target in follicular lymphoma","volume":"35","author":"Valero","year":"2021","journal-title":"Leukemia"},{"key":"B156","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s13046-020-01747-z","article-title":"Mir-7e-5p downregulation promotes transformation of low-grade follicular lymphoma to aggressive lymphoma by modulating an immunosuppressive stroma through the upregulation of fasl in M1 macrophages","volume":"39","author":"Lou","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"B157","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ccell.2024.11.011","article-title":"Cytokines in cancer","volume":"43","author":"Kureshi","year":"2025","journal-title":"Cancer Cell"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.872010","article-title":"Cytokine based immunotherapy for cancer and lymphoma: biology, challenges and future perspectives","volume":"13","author":"Atallah-Yunes","year":"2022","journal-title":"Front Immunol"},{"key":"B159","doi-asserted-by":"publisher","first-page":"E498","DOI":"10.1073\/pnas.1715118115","article-title":"Gene regulation and suppression of type I interferon signaling by stat3 in diffuse large B cell lymphoma","volume":"115","author":"Lu","year":"2018","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2025.01.003","article-title":"Insights into il-6\/jak\/stat3 signaling in the tumor microenvironment: implications for cancer therapy","volume":"85","author":"Thuya","year":"2025","journal-title":"Cytokine Growth Factor Rev"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.24441","article-title":"Regulation of cellular processes by interleukin-16 in homeostasis and cancer","volume":"229","author":"Richmond","year":"2014","journal-title":"J Cell Physiol"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2024.285304","article-title":"Lymphoma cell-driven il-16 is expressed in activated B-cell-like diffuse large B-cell lymphomas and regulates the pro-tumor microenvironment","volume":"110","author":"Guan","year":"2025","journal-title":"Haematologica"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2016.03.006","article-title":"Relationship between il-10 gene polymorphisms and the risk of non-hodgkin lymphoma: A meta-analysis","volume":"77","author":"Li","year":"2016","journal-title":"Hum Immunol"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2020.106371","article-title":"High serum levels of il-2r, il-6, and tnf-A Are associated with higher tumor burden and poorer outcome of follicular lymphoma patients in the rituximab era","volume":"94","author":"Mozas","year":"2020","journal-title":"Leuk Res"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2023.156289","article-title":"Cytokine profiles in patients with newly diagnosed diffuse large B-cell lymphoma: il-6 and il-10 levels are associated with adverse clinical features and poor outcomes","volume":"169","author":"Bao","year":"2023","journal-title":"Cytokine"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.104782","article-title":"Impact of the tumor microenvironment on progression and treatment response in lymphoma and chronic lymphocytic leukemia: A systematic review of the literature","volume":"213","author":"Castellanos","year":"2025","journal-title":"Crit Rev Oncol Hematol"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2025.189344","article-title":"Interactions between cancer cells and tumor-associated macrophages in tumor microenvironment","volume":"1880","author":"Liu","year":"2025","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16203553","article-title":"Impact of the immune landscape in follicular lymphoma: insights into histological transformation in the rituximab era","volume":"16","author":"Enemark","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201910576","article-title":"The il-6 signaling complex is a critical driver, negative prognostic factor, and therapeutic target in diffuse large B-cell lymphoma","volume":"11","author":"Hashwah","year":"2019","journal-title":"EMBO Mol Med"},{"key":"B170","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12943-024-02023-w","article-title":"Regulatory mechanisms of pd-1\/pd-L1 in cancers","volume":"23","author":"Lin","year":"2024","journal-title":"Mol Cancer"},{"key":"B171","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.cmet.2022.08.002","article-title":"Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of I\u03bab\u03b1","volume":"34","author":"Guo","year":"2022","journal-title":"Cell Metab"},{"key":"B172","doi-asserted-by":"publisher","first-page":"6692","DOI":"10.1038\/ncomms7692","article-title":"Pd-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation","volume":"6","author":"Patsoukis","year":"2015","journal-title":"Nat Commun"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.25.21.9543-9553.2005","article-title":"Ctla-4 and pd-1 receptors inhibit T-cell activation by distinct mechanisms","volume":"25","author":"Parry","year":"2005","journal-title":"Mol Cell Biol"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20174158","article-title":"Tumor metabolism as a regulator of tumor-host interactions in the B-cell lymphoma microenvironment-fueling progression and novel brakes for therapy","volume":"20","author":"Beielstein","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.9061","article-title":"Co-expression of pd-L1 and P-akt is associated with poor prognosis in diffuse large B-cell lymphoma via pd-1\/pd-L1 axis activating intracellular akt\/mtor pathway in tumor cells","volume":"7","author":"Dong","year":"2016","journal-title":"Oncotarget"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-14-3362","article-title":"Control of pd-L1 expression by oncogenic activation of the akt-mtor pathway in non-small cell lung cancer","volume":"76","author":"Lastwika","year":"2016","journal-title":"Cancer Res"},{"key":"B177","doi-asserted-by":"publisher","first-page":"4355","DOI":"10.1016\/j.cell.2024.07.016","article-title":"Lag-3 and pd-1 synergize on cd8(+) T cells to drive T cell exhaustion and hinder autocrine ifn-\u0393-dependent anti-tumor immunity","volume":"187","author":"Andrews","year":"2024","journal-title":"Cell"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-11-1620","article-title":"Immune inhibitory molecules lag-3 and pd-1 synergistically regulate T-cell function to promote tumoral immune escape","volume":"72","author":"Woo","year":"2012","journal-title":"Cancer Res"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2004.08.010","article-title":"Role of lag-3 in regulatory T cells","volume":"21","author":"Huang","year":"2004","journal-title":"Immunity"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2023.11.007","article-title":"Metabolic interplay: tumor macrophages and regulatory T cells","volume":"10","author":"Vilbois","year":"2024","journal-title":"Trends Cancer"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2376","article-title":"Tumor-infiltrating dcs suppress nucleic acid-mediated innate immune responses through interactions between the receptor tim-3 and the alarmin hmgb1","volume":"13","author":"Chiba","year":"2012","journal-title":"Nat Immunol"},{"key":"B182","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12967-024-05002-3","article-title":"Diffuse large B-cell lymphoma: the significance of cd8(+) tumor-infiltrating lymphocytes exhaustion mediated by tim3\/galectin-9 pathway","volume":"22","author":"Zhu","year":"2024","journal-title":"J Transl Med"},{"key":"B183","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/imr.12520","article-title":"Tim-3 and its role in regulating anti-tumor immunity","volume":"276","author":"Das","year":"2017","journal-title":"Immunol Rev"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0206-z","article-title":"Induction and transcriptional regulation of the co-inhibitory gene module in T cells","volume":"558","author":"Chihara","year":"2018","journal-title":"Nature"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000911","article-title":"Tim-3 finds its place in the cancer immunotherapy landscape","volume":"8","author":"Acharya","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2023.12.016","article-title":"Pet\/ct reconstruction and its impact on [Measures of] metabolic tumor volume","volume":"31","author":"Knaup","year":"2024","journal-title":"Acad Radiol"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1016\/s1095-0397(99)00016-3","article-title":"Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using pet-fdg imaging. The visual response score and the change in total lesion glycolysis","volume":"2","author":"Larson","year":"1999","journal-title":"Clin Positron Imaging"},{"key":"B188","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s13139-017-0493-6","article-title":"Current methods to define metabolic tumor volume in positron emission tomography: which one is better","volume":"52","author":"Im","year":"2018","journal-title":"Nucl Med Mol Imaging"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.111.099531","article-title":"18f-fdg metabolic tumor volume and total glycolytic activity of oral cavity and oropharyngeal squamous cell cancer: adding value to clinical staging","volume":"53","author":"Dibble","year":"2012","journal-title":"J Nucl Med"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2013.53.5229","article-title":"Role of imaging in the staging and response assessment of lymphoma: consensus of the international conference on Malignant lymphomas imaging working group","volume":"32","author":"Barrington","year":"2014","journal-title":"J Clin Oncol"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-024-05717-9","article-title":"Metabolic Tumor Volume from Baseline [18 f]Fdg Pet\/Ct at Diagnosis Improves the Ipi Stratification in Patients with Diffuse Large B-Cell Lymphoma","volume":"103","author":"Zhang","year":"2024","journal-title":"Ann Hematol"},{"key":"B192","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s12935-021-02094-5","article-title":"Significance of initial, interim and end-of-therapy (18)F-fdg pet\/ct for predicting transformation risk in follicular lymphoma","volume":"21","author":"Xie","year":"2021","journal-title":"Cancer Cell Int"},{"key":"B193","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12916-025-03893-7","article-title":"Virtual biopsy for non-invasive identification of follicular lymphoma histologic transformation using radiomics-based imaging biomarker from pet\/ct","volume":"23","author":"Jiang","year":"2025","journal-title":"BMC Med"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.10.121","article-title":"Metabolic tumor volume predicts outcome in patients with advanced stage follicular lymphoma from the relevance trial","volume":"35","author":"Cottereau","year":"2024","journal-title":"Ann Oncol"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.263194","article-title":"Baseline suvmax is related to tumor cell proliferation and patient outcome in follicular lymphoma","volume":"107","author":"Rossi","year":"2022","journal-title":"Haematologica"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210224","article-title":"Prognostic value of baseline metabolic tumor volume and total lesion glycolysis in patients with lymphoma: A meta-analysis","volume":"14","author":"Guo","year":"2019","journal-title":"PloS One"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2021.278663","article-title":"Total metabolic tumor volume as a survival predictor for patients with diffuse large B-cell lymphoma in the goya study","volume":"107","author":"Kostakoglu","year":"2022","journal-title":"Haematologica"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2018.649","article-title":"Prognostic value of baseline and interim total metabolic tumor volume and total lesion glycolysis measured on 18f-fdg pet-ct in patients with follicular lymphoma","volume":"51","author":"Liang","year":"2019","journal-title":"Cancer Res Treat"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-014-2961-x","article-title":"Fdg pet\/ct: eanm procedure guidelines for tumour imaging: version 2.0","volume":"42","author":"Boellaard","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-23-1554","article-title":"Tumor-infiltrating normal B cells revealed by immunoglobulin repertoire clonotype analysis are highly prognostic and crucial for antitumor immune responses in dlbcl","volume":"29","author":"Xu-Monette","year":"2023","journal-title":"Clin Cancer Res"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-018-2466-7","article-title":"Cd3+\/cd8+ T-cell density and tumoral pd-L1 predict survival irrespective of rituximab treatment in chinese diffuse large B-cell lymphoma patients","volume":"108","author":"Shi","year":"2018","journal-title":"Int J Hematol"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2024.286267","article-title":"Characterization of tumor microenvironment and cell interaction patterns in testicular and diffuse large B-cell lymphomas","volume":"110","author":"Autio","year":"2025","journal-title":"Haematologica"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-018-3266-0","article-title":"High pd-L1 expression predicts poor prognosis in diffuse large B-cell lymphoma","volume":"97","author":"Cheng","year":"2018","journal-title":"Ann Hematol"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-020-00589-y","article-title":"Pd-1\/pd-L1 pathway and its blockade in patients with classic hodgkin lymphoma and non-hodgkin large-cell lymphomas","volume":"15","author":"Xie","year":"2020","journal-title":"Curr Hematol Malig Rep"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1265255","article-title":"Blockade of pd-1 and lag-3 expression on cd8+ T cells promotes the tumoricidal effects of cd8+ T cells","volume":"14","author":"Ma","year":"2023","journal-title":"Front Immunol"},{"key":"B206","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s43046-025-00303-0","article-title":"Immunohistochemical expression of pd1, lag3, and ctla4 in diffuse large B cell lymphoma, clinicopathological correlation, and prognostic value","volume":"37","author":"William","year":"2025","journal-title":"J Egypt Natl Canc Inst"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2015.08.037","article-title":"Prognostic value of pd-1 and tim-3 on cd3+ T cells from diffuse large B-cell lymphoma","volume":"75","author":"Zhang","year":"2015","journal-title":"BioMed Pharmacother"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.26771","article-title":"The immune checkpoint molecules pd-1, pd-L1, tim-3 and lag-3 in diffuse large B-cell lymphoma","volume":"10","author":"Chen","year":"2019","journal-title":"Oncotarget"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106684","article-title":"Prognostic value of tissue-infiltrating immune cells in tumor microenvironment of follicular lymphoma: A meta-analysis","volume":"85","author":"Xie","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.2147\/ott.S289337","article-title":"Pd-1 expression in pre-treatment follicular lymphoma predicts the risk of subsequent high-grade transformation","volume":"14","author":"Beck Enemark","year":"2021","journal-title":"Onco Targets Ther"},{"key":"B211","doi-asserted-by":"publisher","first-page":"e555","DOI":"10.1038\/bcj.2017.32","article-title":"Ezh2 alterations in follicular lymphoma: biological and clinical correlations","volume":"7","author":"Huet","year":"2017","journal-title":"Blood Cancer J"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2023.869","article-title":"Feasibility of circulating tumor DNA analysis in patients with follicular lymphoma","volume":"56","author":"Yoon","year":"2024","journal-title":"Cancer Res Treat"},{"key":"B213","doi-asserted-by":"publisher","first-page":"e1002197","DOI":"10.1371\/journal.pmed.1002197","article-title":"Histological transformation and progression in follicular lymphoma: A clonal evolution study","volume":"13","author":"Kridel","year":"2016","journal-title":"PloS Med"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024026020","article-title":"Biology as vulnerability in follicular lymphoma: genetics, epigenetics, and immunogenetics","volume":"16","author":"Araujo-Ayala","year":"2025","journal-title":"Blood"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.18251","article-title":"Expression of lag-3 defines exhaustion of intratumoral pd-1(+) T cells and correlates with poor outcome in follicular lymphoma","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1172\/jci59806","article-title":"Il-12 upregulates tim-3 expression and induces T cell exhaustion in patients with follicular B cell non-hodgkin lymphoma","volume":"122","author":"Yang","year":"2012","journal-title":"J Clin Invest"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2022.100822","article-title":"Targeting metabolism to overcome cancer drug resistance: A promising therapeutic strategy for diffuse large B cell lymphoma","volume":"61","author":"Pi","year":"2022","journal-title":"Drug Resist Update"},{"key":"B218","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.semcancer.2015.07.004","article-title":"Microenvironment abnormalities and lymphomagenesis: immunological aspects","volume":"34","author":"Taylor","year":"2015","journal-title":"Semin Cancer Biol"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0914433107","article-title":"Inhibition of lactate dehydrogenase a induces oxidative stress and inhibits tumor progression","volume":"107","author":"Le","year":"2010","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-17-2285","article-title":"Discovery of ido1 inhibitors: from bench to bedside","volume":"77","author":"Prendergast","year":"2017","journal-title":"Cancer Res"},{"key":"B221","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12943-023-01733-x","article-title":"Cd39\/cd73\/A2ar pathway and cancer immunotherapy","volume":"22","author":"Xia","year":"2023","journal-title":"Mol Cancer"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.3343\/alm.2023.0443","article-title":"Metformin suppresses both pd-L1 expression in cancer cells and cancer-induced pd-1 expression in immune cells to promote antitumor immunity","volume":"44","author":"Park","year":"2024","journal-title":"Ann Lab Med"},{"key":"B223","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13045-023-01499-1","article-title":"Targeting lag-3, tim-3, and tigit for cancer immunotherapy","volume":"16","author":"Cai","year":"2023","journal-title":"J Hematol Oncol"},{"key":"B224","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1349-7006.2010.01767.x","article-title":"Immunopathogenesis of lymphoma: focus on ccr4","volume":"102","author":"Ishida","year":"2011","journal-title":"Cancer Sci"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-024-06071-6","article-title":"Development and validation of prognostic models based on (18)F-fdg pet radiomics, metabolic parameters, and clinical factors for elderly dlbcl patients","volume":"103","author":"Yang","year":"2024","journal-title":"Ann Hematol"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2025.101206","article-title":"New horizons in B-cell lymphoma immunotherapy: from immune checkpoints to precision medicine","volume":"67","author":"Zheng","year":"2025","journal-title":"Neoplasia"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01803-x","article-title":"Real-life disease monitoring in follicular lymphoma patients using liquid biopsy ultra-deep sequencing and pet\/ct","volume":"37","author":"Jim\u00e9nez-Ubieto","year":"2023","journal-title":"Leukemia"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19458","article-title":"Liquid biopsy for molecular characterization of diffuse large B-cell lymphoma and early assessment of minimal residual disease","volume":"205","author":"Alcoceba","year":"2024","journal-title":"Br J Haematol"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-021-02234-9","article-title":"The follicular lymphoma epigenome regulates its microenvironment","volume":"41","author":"Amin","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2020.1824643","article-title":"Improving the anti-solid tumor efficacy of car-T cells by inhibiting adenosine signaling pathway","volume":"9","author":"Li","year":"2020","journal-title":"Oncoimmunology"},{"key":"B231","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1038\/s41467-021-23331-5","article-title":"Crispr\/cas9 mediated deletion of the adenosine A2a receptor enhances car T cell efficacy","volume":"12","author":"Giuffrida","year":"2021","journal-title":"Nat Commun"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024025755","article-title":"Il-10 from tumoral B cells modulates the diffuse large B-cell lymphoma microenvironment and response to immunotherapy","volume":"145","author":"Garcia-Lacarte","year":"2025","journal-title":"Blood"},{"key":"B233","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41420-024-01807-9","article-title":"Fatty acid metabolism of immune cells: A new target of tumour immunotherapy","volume":"10","author":"Zhang","year":"2024","journal-title":"Cell Death Discov"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1659011\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T05:51:11Z","timestamp":1759297871000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1659011\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":233,"alternative-id":["10.3389\/fimmu.2025.1659011"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1659011","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"article-number":"1659011"}}